Ultrastructural Localization of P-glycoprotein on Capillary Endothelial Cells in Human Gliomas
Overview
Molecular Biology
Pathology
Affiliations
The P-glycoprotein (P-Gp) encoded by the human multidrug-resistance gene MDR1 has been suggested to play certain roles in the blood-brain barrier (BBB). However, the detailed mechanism of the activity of P-Gp in multidrug-resistance (MDR) remains unclear in human glioma. We examined the localization of P-Gp in human glioma by immunohistochemical (IHC) and immunoelectron microscopic (IEM) methods with anti P-Gp monoclonal antibodies (C219, MRK16). We also examined MDR1 expression in primary glioma and xenografts by reverse transcription-polymerase chain reaction (RT-PCR) with human MDR1-specific primers. The IHC study showed no P-Gp expression on tumour cells but it was present on capillary endothelial cells and IEM analysis showed definitive localization on their luminal surface. MDR1 gene expression was detected in eight primary glioma and three normal brain specimens by RT-PCR, but not in glioma xenografts. The lack of MDR1 expression in these cells appears to be a consequence of the replacement of the original human stroma, including blood vessels, by murine stroma in glioma xenografts. The unique distribution of P-Gp on the capillary blood vessels was confirmed in human glioma by the results of immunohistochemical and molecular biological studies.
The impact of ATP-binding cassette transporters in the diseased brain: Context matters.
Baltira C, Aronica E, Elmquist W, Langer O, Loscher W, Sarkaria J Cell Rep Med. 2024; 5(6):101609.
PMID: 38897176 PMC: 11228798. DOI: 10.1016/j.xcrm.2024.101609.
Acquired and intrinsic resistance to vemurafenib in BRAF -driven melanoma brain metastases.
Zhang P, Kuil L, Buil L, Freriks S, Beijnen J, van Tellingen O FEBS Open Bio. 2023; 14(1):96-111.
PMID: 37953496 PMC: 10761933. DOI: 10.1002/2211-5463.13730.
Contribution of Direct Cerebral Vascular Transport in Brain Substance Clearance.
Wen Q, Wang H, Haacke E, Jiang Q, Hu J Aging Dis. 2023; 15(2):584-600.
PMID: 37611901 PMC: 10917538. DOI: 10.14336/AD.2023.0426.
Schulz J, Hartz A, Bauer B Pharmacol Rev. 2023; 75(5):815-853.
PMID: 36973040 PMC: 10441638. DOI: 10.1124/pharmrev.120.000025.
Gomez-Zepeda D, Taghi M, Scherrmann J, Decleves X, Menet M Pharmaceutics. 2019; 12(1).
PMID: 31878061 PMC: 7022905. DOI: 10.3390/pharmaceutics12010020.